Polypharmacy is an Indicator of Bad Practice and Low Quality in General Medicine

Journal Title: Journal of Quality in Health Care & Economics (JQHE) - Year 2019, Vol 2, Issue 4

Abstract

Quality indicators are increasingly used as a tool to achieve safe and quality clinical care. A significant number of them focus on drug therapy, but few address the problem of polypharmacy in general medicine. All patients, especially elderly patients, those with certain pathologies, those with multimorbidity, or those who live in institutions, are exposed to polypharmacy. The prescription of contraindicated or potentially inappropriate medications is also common. Although polypharmacy is sometimes unavoidable, this indicator has been associated with increased morbidity and mortality. The prevalence of polypharmacy is high, and could reach 20%. But, the main thing is that there is a great variability among general practitioners (GPs), which can vary from 4-5% until 18-30% according to GP, in the same geographical area and with lists of random and similar patients. Thus, the main cause of polypharmacy (of excessive use of drugs) is the professional; the prevalence of polypharmacy does not justify itself exclusively by the presence of the multimorbidity or of elderly people, neither is randomly distributed. Polypharmacy does not depend on the size GP' patients list (large lists may have little polypharmacy and small lists a lot of polypharmacy). It can be hypothesized that the presence of polypharmacy is an indicator of malpractice and poor quality of the general medical service, which should be used to improve the clinical care of patients. Therefore, it is imperative to monitor and optimize the use of medications in general medicine. This creates an opportunity to minimize adverse outcomes related to the use of medications and to improve the quality of care, possible cost savings and improve clinical outcomes. Additional research should deepen this proposal that high frequency of polypharmacy between different practices in general medicine is an indicator of poor quality of care in those GPs.

Authors and Affiliations

Turabian JL*

Keywords

Related Articles

Unmasking and Managing Hypercalcaemia-In Clinical Settings!

Objective: In this article I present 2 cases of hypercalcaemia identified and managed in 2021 in smaller settings and review of literature of such cases in bigger facilities India with an objective of alerting private pr...

Covid 19 Pandemic & Women’s Health Pregnancy, Parturition & Postpartum Problems & Vaccination Challenges

Th global dilemma of Covid 19 pandemic, is just 30-40% of COVID-19 cases have been disaggregated by both sex and age. Many anecdotal studies in different countries indicate a higher incidence, mortality, and fatality rat...

Eating Disorder Prevention: Economic Considerations for College Students

Eating disorders (EDs) are mental health disorders causing severe disturbances to the eating behaviors of individuals.

Business Cycles Analysis in Cameroon: An Overview

This paper aims at conducting a thorough analysis of business cycles in Cameroon by statistically assessing their main characteristics. The analysis is carried out by considering the three dimensions of macroeconomic flu...

Orthoptists Services: A Review of Benefits Paid By Medical Schemes, South Africa

Background: Orthoptists are specialists in diagnosing and treating ocular movement disorders and problems related to how the eyes work together, known as binocular vision. There is currently about 1 100 orthoptist regist...

Download PDF file
  • EP ID EP746485
  • DOI 10.23880/jqhe-16000130
  • Views 54
  • Downloads 0

How To Cite

Turabian JL* (2019). Polypharmacy is an Indicator of Bad Practice and Low Quality in General Medicine. Journal of Quality in Health Care & Economics (JQHE), 2(4), -. https://europub.co.uk/articles/-A-746485